Recent Advances in HIV-1 Gag Inhibitor Design and Development
Acquired Immune Deficiency Syndrome (AIDS) treatment with combination antiretroviral therapy (cART) has improved the life quality of many patients since its implementation. However, resistance mutations and the accumulation of severe side effects associated with cART remain enormous challenges that...
Main Authors: | Alexej Dick, Simon Cocklin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/7/1687 |
Similar Items
-
The Conserved Tyr176/Leu177 Motif in the α-Helix 9 of the Feline Immunodeficiency Virus Capsid Protein Is Critical for Gag Particle Assembly
by: César A. Ovejero, et al.
Published: (2019-09-01) -
Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients
by: Supachai Sakkhachornphop, et al.
Published: (2018-11-01) -
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
by: Xujie Zhang, et al.
Published: (2022-11-01) -
The HIV-1 gag p6: a promising target for therapeutic intervention
by: Xiaowei Chen, et al.
Published: (2024-01-01) -
Specific Interaction of DARPin with HIV-1 CA<sub>NTD</sub> Disturbs the Distribution of Gag, RNA Packaging, and Tetraspanin Remodelling in the Membrane
by: Sutpirat Moonmuang, et al.
Published: (2022-04-01)